Comparison · 2026-06-04
Flat-Rate vs Dose-Based Semaglutide Pricing
The two dominant pricing models for compounded semaglutide, and how to tell which one is cheaper for your situation.
Quick Answer
Flat-rate pricing charges the same monthly amount at every dose; dose-based (tiered) pricing rises as your dose increases. Flat-rate usually wins for patients who reach higher maintenance doses, while a low intro/tiered plan can win for short courses or low doses. Compare at your expected maintenance dose, not the starter price.
| Flat-rate | Dose-based (tiered) | |
|---|---|---|
| How price changes | Same at every dose | Rises as dose increases |
| Best for | Higher maintenance doses, long courses | Low doses, short trials, intro pricing |
| Example models | Mochi ($99 med, flat), Eden (flat after first month) | Henry Meds (escalates), some MEDVi tiers |
| Watch for | Membership fees on top (e.g., Mochi $79) | Cost jumps at titration; promo first month |
Key Facts
- Flat-rate removes titration price hikes; dose-based does not.
- A membership fee can erase a flat plan’s advantage — count the all-in total.
- Your maintenance dose drives long-run cost more than the starter price.
What to Verify
- Whether the flat rate truly holds across the full titration.
- Any required membership or platform fee.
- The price at your specific target dose.
Bottom Line
Model both with the starter-vs-maintenance and dose-increase calculators, then compare all-in totals at your maintenance dose.
Compounded semaglutide is not FDA-approved as a finished drug product. Compounded medications may be prescribed only when clinically appropriate and must be evaluated by a licensed prescriber. Branded medications such as Wegovy and Ozempic are FDA-approved products; compounded semaglutide is different and should not be described as FDA-approved, “generic Wegovy,” or “generic Ozempic.”